This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
27 November 2023
Quadrise Plc
("Quadrise" or the "Company")
AGM Statement
Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, is pleased to provide the following update ahead of the Company's Annual General Meeting ("AGM") which commences today at 12 noon.
At the conclusion of the AGM, the Company will provide a business update presentation to shareholders present at the venue and online via the Investor Meet Company ("IMC") platform. The presentation is open to all existing and potential investors. Those wishing to attend online via IMC can register via: https://www.investormeetcompany.com/quadrise-plc/register-investor
2023 Overview and Update
The Company's recently published 2023 sustainability report set out our efforts to address demand for solutions to decarbonise shipping, and to build capacity for the supply of our low-carbon fuels in the US. In advance of the anticipated developments outlined below, a formal process is now underway to seek commercial partners in both the marine and US-focused low-carbon fuel markets who would be able to contribute the resources necessary to scale up growth rapidly once trials have been completed.
In this regard, we have also been particularly heartened by the success of bioMSAR™ in Morocco, as announced on 22 November 2023, demonstrating the viability of bioMSAR™ in an industrial application. Building on this, there has been considerable RDI progress at the Quadrise Research Facility ("QRF") with commercial partners to develop bioMSAR™ formulations using lower cost, lower-carbon, and globally abundant biomass-derived sugars produced using various technologies. This is a clear pointer to the future for the Company as the need for commercially competitive net-zero fuel solutions grows in urgency.
The Company's progress in each of its key projects towards their next stages is described below.
Key projects:
Morocco: The industrial demonstration test of MSAR® and bioMSAR™ fuels at the client's site in Morocco was successfully completed, as announced on 22 November 2023. This was the first demonstration of bioMSAR™ in a commercial application and Quadrise is now preparing a technical report to submit to the client within the next month. The parties now look forward to entering into discussions for long-term commercial supply in conjunction with reaching an agreement for testing at other client sites to expand supply opportunities for MSAR®, and in the future, bioMSAR™ fuels.
Marine: Agreements with project stakeholders covering the Proof-of-Concept and Letter Of No Objection ("LONO") commercial trials on bioMSAR™ with MSC Shipmanagement ("MSC") are expected to be concluded in December 2023. The agreements cover trial fuel production, supply, and logistics. Provided these and the relevant permits are concluded in time, Quadrise equipment will be installed and commissioned at the bunker terminal in Q1 2024, with the intention to commence the trials in early Q2 2024, in accordance with the latest vessel schedule shared by MSC recently.
US low carbon fuels: Quadrise understands that Valkor Technologies LLC ("Valkor") expects to conclude drilling permits and project financing relating to their primary project site in Utah by the end of the calendar year 2023. Provided a minimum of US$15 million is successfully raised by Valkor, under the terms of the Site License and Supply Agreement signed in June 2023, Valkor will pay Quadrise an initial US$1.0 million licence fee and a further US$0.5 million upon delivery of an MSAR® Manufacturing Unit to the project site in Utah.
bioMSAR™ development
As described in the overview above, during FY23 and since the period end, work has been progressing at the QRF in conjunction with commercial partners Vertoro BV and BTG Bioliquids BV, as well as with other prospective partners, to develop bioMSAR™ formulations made using biomass-derived sugars. These are a lower cost and more globally abundant future alternative to glycerine and would enable a lower cost, lower carbon biofuel alternative to be produced which could then be marketed at scale to the marine and industrial sectors. Discussions have been progressing with other stakeholders in this renewable sector.
In November 2023, diesel engine testing was completed at Aquafuel on blends of bioMSAR™ containing 20% to 40% of Vertoro's crude sugar oil (CSO™). The testing demonstrated improved engine efficiency and lower Nitrogen oxide ("NOx") and particulate emissions upon combustion when compared to conventional diesel. Quadrise and Vertoro are now discussing the next steps toward commercialisation of the CSO™ bioMSAR™ blends. Aquafuel tests were also completed using blends of marine B30 biofuels containing FAME in MSAR® and bioMSAR™ to assess engine efficiency and emissions improvements, both of which were positive and a further step towards bioMSAR™ Zero.
Commenting on the update, Jason Miles, Chief Executive Officer of QED, said:
"During 2023, we have continued to make progress with each of our key projects as well as with our work to supply bioMSAR™ at commercial scale and develop lower carbon biofuel alternatives using biomass derived sugars. We were particularly pleased to note the first commercial scale demonstration of bioMSAR in Morocco, where the client's industrial unit was successfully operated at varying loads of up to 100%, equivalent to the energy consumption of a medium-sized container ship.
The progress made in Morocco is vitally important to the Company as we look to progress to commercial supply there and to commence marine trials on board the MSC Leandra in H1 2024. Preparations for the MSC trials are now underway, with agreements expected to be signed by year-end. In addition, the Company expects to deliver commercial revenues from Valkor in the near future upon successful closure of Valkor's project financing.
The progress at QRF and Aquafuel with commercial partners to develop and trial bioMSAR™ formulations using cheaper and globally abundant biomass derived sugars provides a clear pointer to the future for the Company, since a lower carbon biofuel alternative will be demanded by the marine and industrial sectors.
To prepare for the expected growth of MSAR® and bioMSAR™ sales, a structured process is now underway to seek commercial partners that would allow the Company to be able to quickly scale up once the key project milestones have been met and we look forward to updating shareholders on this exercise in due course.
On behalf of the board, I would once again like to thank our loyal shareholders for their continued support, and I look forward to seeing many of you at the AGM in person."
For additional information, please contact:
Quadrise Plc | | +44 (0)20 7031 7321 |
Andy Morrison, Chairman Jason Miles, Chief Executive Officer | | |
| | |
Nominated Adviser | | |
Cavendish Capital Markets Limited | | +44 (0)20 7220 0500 |
Ben Jeynes | | |
Katy Birkin | | |
Joint Brokers Shore Capital Stockbrokers Limited | |
+44 (0)20 7408 4090 |
Toby Gibbs, Rachel Goldstein (Corporate Advisory) | | |
Fiona Conroy (Corporate Broking) | | |
|
|
|
VSA Capital Limited Andrew Raca (Corporate Finance) Andrew Monk (Corporate Broking) | | +44 (0)20 3005 5000 |
| | |
Public & Investor Relations |
|
|
Vigo Consulting Patrick D'Ancona Finlay Thomson | | +44 (0)20 7390 0230 |
About Quadrise
Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.
Learn more at: www.quadrise.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.